<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00229450</url>
  </required_header>
  <id_info>
    <org_study_id>NARSAD06806-001</org_study_id>
    <secondary_id>06806-001</secondary_id>
    <secondary_id>04-05-088</secondary_id>
    <nct_id>NCT00229450</nct_id>
  </id_info>
  <brief_title>Estrogen and Perimenopausal Depression</brief_title>
  <official_title>Dose Response Effects of Estrogen Augmentation in Mood &amp; Memory in Perimenopausal Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Alliance for Research on Schizophrenia and Depression</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <brief_summary>
    <textblock>
      During perimenopause (the time just prior to menopause), women often notice many biological,
      psychological, and social changes. In particular, some women experience depressive symptoms
      during perimenopause that are severe enough to warrant antidepressant medication. Whether or
      not women with perimenopausal depression respond to antidepressant medication may depend on
      the level of estrogen in their blood. We would like to investigate whether estrogen will help
      the women who only partially respond to antidepressant medications. We also want to examine
      how different doses of estrogen may affect individuals differently.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2004</start_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mood</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Memory</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Depressive Disorder, Major</condition>
  <condition>Menopause</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>estrogen</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical Diagnosis of Unipolar Major Depression, currently taking antidepressants

          -  HAM-D between 10 and 17

        Exclusion Criteria:

          -  History of Psychosis, breast cancer, smoking, dementia, clotting disorders

          -  Current substance abuse
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Melinda L. Morgan, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Melinda L. Morgan, Ph.D.</last_name>
    <phone>310-825-5028</phone>
    <email>melinda@ucla.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>UCLA Neuropsychiatric Institute &amp; Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jodie B. Cohen, B.S.</last_name>
      <phone>310-825-0528</phone>
      <email>jodie@mentalhealth.ucla.edu</email>
    </contact>
    <investigator>
      <last_name>Ian A. Cook, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew F. Leuchter, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. J Clin Psychiatry. 2005 Jun;66(6):774-80.</citation>
    <PMID>15960574</PMID>
  </reference>
  <reference>
    <citation>Cook IA, Morgan ML, Dunkin JJ, David S, Witte E, Lufkin R, Abrams M, Rosenberg S, Leuchter AF. Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study. Int J Geriatr Psychiatry. 2002 Jul;17(7):610-8.</citation>
    <PMID>12112157</PMID>
  </reference>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 28, 2005</study_first_submitted>
  <study_first_submitted_qc>September 28, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2005</study_first_posted>
  <last_update_submitted>June 2, 2008</last_update_submitted>
  <last_update_submitted_qc>June 2, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2008</last_update_posted>
  <keyword>depression</keyword>
  <keyword>menopause</keyword>
  <keyword>perimenopause</keyword>
  <keyword>mood</keyword>
  <keyword>memory</keyword>
  <keyword>perimenopausal</keyword>
  <keyword>antidepressant</keyword>
  <keyword>estrogen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Estrogens</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

